A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With Fibromyalgia
Clinical trial NCT05273749 · COMPLETED
Trial details
- NCT number
- NCT05273749
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-06
- Primary completion
- 2023-11-14
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.